Page last updated: 2024-08-23

paroxetine and Substance Withdrawal Syndrome

paroxetine has been researched along with Substance Withdrawal Syndrome in 99 studies

Research

Studies (99)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	36 (36.36)	18.2507
2000's	52 (52.53)	29.6817
2010's	10 (10.10)	24.3611
2020's	1 (1.01)	2.80

Authors

Authors	Studies
Cattaneo, CI; De Berardis, D; Fornaro, M; Martinotti, G; Ressico, FV; Vieta, E	1
Dienel, A; Gastpar, M; Kasper, S; Möller, HJ; Müller, WE; Schläfke, S; Volz, HP	1
Baandrup, L; Ebdrup, BH; Glenthøj, BY; Gluud, C; Lindschou, J; Rasmussen, JØ	1
Jha, MK; Rush, AJ; Trivedi, MH	1
Brandt, L; Bschor, T; Heinz, A; Henssler, J	1
Groot, PC	1
Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ	1
Bramanti, P; Caputi, AP; Cordici, F; Grugno, R; Polimeni, G; Vitetta, A	1
Jureidini, J; Mintzes, B	1
Bartolic, EI; Carfagno, M; Iyengar, M; Lipschitz, A; Lydiard, RB; Pitts, CD; Rapaport, MH; Schaefer, D	1
Goldstein, I; Kellner, CH; Korda, JB; Pfaus, JG	1
Haraguchi, K; Ieiri, I; Imuta, N; Kobayashi, D; Koyama, S; Mine, K; Murata, Y; Nishimura, R	1
Collins, A; Gragg, M; Sherrod, RA; Wynn, S	1
Kaneko, S; Yasui-Furukori, N	1
Akiyoshi, J; Hanada, H; Ishitobi, Y; Kanehisa, M; Kawano, Y; Shimomura, T; Tanaka, Y; Tsuru, J	1
Jacobson, JG; Judge, R; Parry, MG; Quail, D	1
Finfgeld, DL	1
Fortmann, SP; Hayward, C; Killen, JD; Schatzberg, A; Varady, A	1
Bull, EJ; Fone, KC; Hutson, PH	1
Aragües, E; Etxebeste, M; Malo, P; Medrano, J; Pacheco Yáñez, L	1
Green, B	1
Downes, F; Isbister, GK; Whyte, IM	1
Bryson, H; Hewett, K; Iyengar, MK; Jokinen, RH; Lepola, UM; Nordera, G; Stocchi, F	1
Ramasubbu, R	1
Jagiellowicz, J	1
Cohen, BM; Frederick, Bd; Hennen, J; Henry, ME; Kaufman, MJ; Renshaw, PF; Schmidt, ME; Stoddard, EP; Villafuerte, RA	1
Hayakawa, Y; Sekine, A; Shimizu, T	1
Martini, P; Mazzatenta, C; Peonia, G	1
Dursun, SM; Haddad, PM	1
Burrows, GD; Hindmarch, I; Kennedy, SH; Lejoyeux, M; Montgomery, SA	1
Chevrette, J; Harrison, AA; Hoyer, D; Markou, A	1
Cabanac, F; Panconi, E; Pezous, N; Sechter, D; Tournoux, A; Vandel, P; Weiller, E	1
Berger, M; Billiard, M; Chalabreysse, M; Durst, P; Palazzolo, J; Peyrelong, JP; Vialle, A	1
Egberts, AC; Heerdink, ER; Hugtenburg, JG; van Geffen, EC; van Hulten, RP	1
Berensen, NM; Bloch, M; Braun, A; Calis, K; Grothe, D; Smith, PJ; Stager, SV	1
Baldwin, DS; Lader, M; Montgomery, SA; Nil, R	1
Bhanji, NH; Chouinard, G; Kolivakis, T; Margolese, HC	1
Einarson, A	1
Connolly, A; Stewart, S; Taylor, D	1
Himei, A; Okamura, T	1
Nakao, M; Nomura, K; Takeuchi, T; Teramoto, T; Yano, E	1
Preskorn, SH	1
de Pisa, E; Girardi, P; Kotzalidis, GD; Patrizi, B; Ruberto, G; Savoja, V	1
Burbeck, R; McDonald, L; Pilling, S; Tomson, D	1
Bloch, M; Braun, AR; Rubinow, DR; Stager, SV	1
Debattista, C; Schatzberg, AF	1
Phillips, SD	1
Bushnell, WD; Kreider, MS; Oakes, R; Wheadon, DE	1
Frost, L; Lal, S	1
Gray, AM; Rafieian-Kopaei, M; Sewell, RD; Spencer, PS	1
Pyke, RE	1
Buttolph, ML; Cyr, P; Jenike, MA; Keuthen, NJ; Minichiello, WE; Ricciardi, JA	1
Barr, LC; Goodman, WK; Price, LH	1
Brown, TM; Mareth, TR	1
Lazowick, AL; Levin, GM	1
Fava, GA; Grandi, S	1
Aragues, E; Etxebeste, M; Malo, P; Pacheco, L	1
Bell, CJ; Coupland, NJ; Potokar, JP	1
Pinkofsky, HB; Reeves, RR	1
Arya, DK	1
MacKay, AV; Price, JS; Waller, PC; Wood, SM	1
Landry, P; Roy, L	1
Adès, J; Lejoyeux, M	1
Haddad, P	1
Haddad, P; Kaplan, EM; Lejoyeux, M; Rosenbaum, JF; Schatzberg, AF; Young, AH; Zajecka, J	1
Ashton, CH; Currie, A; Young, AH	1
McNaughton, S; Walker-Kinnear, M	1
Mitchell, S; Tracy, KA; Zajecka, J	1
Ahlner, J; Dahl, ML; Olhager, E	1
Edwards, IR; Fletcher, AP; Lindquist, M; Pettersson, M; Sanderson, JH; Schou, JS; Stahl, MM; Taylor, NF	1
Baumann, P; Bryois, C; Rubin, C; Zbinden, JD	1
Ascroft, RC; Fava, M; Hoog, SL; Krebs, WB; Rosenbaum, JF	1
Schechter, JO	1
Pollock, BG	1
Thompson, C	1
Gram, LF	1
Peeters, FP; Zandbergen, J	1
Kuipers, T; Vergouwen, AC	1
Bakker, A	1
Stanford, BJ; Stanford, SC	1
Amsterdam, J; Apter, J; Fava, M; Londborg, P; Michelson, D; Pagh, L; Tamura, R	1
Hough, DW; Strickland, GM	1
Fagan, M	1
Amsterdam, J; Apter, J; Fava, M; Londborg, P; Michelson, D; Tamura, R; Tepner, RG	1
Belloeuf, L; Hugues, FC; Le Jeunne, C	1
Kirsch, MA; Louie, AK	1
Avci, A; Diler, RS; Tamam, L	1
Fortmann, SP; Hayward, C; Killen, JD; Rothman, M; Schatzberg, AF; Strausberg, L; Sussman, L; Varady, A	1
Haddad, PM; Qureshi, M	1
Einarson, A; Koren, G; Selby, P	1
Couvée, JE; Zitman, FG	1
Devarajan, S; Dursun, SM; Haddad, PM	1
Gersh, T; Hobson, JA; Pace-Schott, EF; Salzman, C; Silvestri, R; Stickgold, R	1
Tonks, A	1
Boulton, DW; DeVane, CL; Goldman, J; Liston, HL; Markowitz, JS; Risch, SC	1
Baumann, P; Lyon, I; Morena, P; Zullino, D	1
Bellino, S; Bogetto, F; Patria, L; Revello, RB	1
Terao, T	1

Reviews

12 review(s) available for paroxetine and Substance Withdrawal Syndrome

Article	Year
Antidepressant discontinuation syndrome: A state-of-the-art clinical review. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2023, Volume: 66 Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2023
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. The Cochrane database of systematic reviews, 2018, Mar-15, Volume: 3 Topics: Adult; Antidepressive Agents; Aspartic Acid; Benzodiazepines; Buspirone; Carbamazepine; Ethylamines; Flumazenil; Homeopathy; Humans; Imidazoles; Lithium Compounds; Melatonin; Paroxetine; Pregabalin; Progesterone; Pyridines; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Sulfides; Withholding Treatment	2018
When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips. The American journal of psychiatry, 2018, 12-01, Volume: 175, Issue:12 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Diagnosis, Differential; Female; Humans; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2018
Antidepressant Withdrawal and Rebound Phenomena. Deutsches Arzteblatt international, 2019, May-17, Volume: 116, Issue:20 Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2019
Focus on paroxetine. Current medical research and opinion, 2003, Volume: 19, Issue:1 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depression; Drug Interactions; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Substance Withdrawal Syndrome; Treatment Outcome	2003
Discontinuation symptoms in depression and anxiety disorders. The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Withholding Treatment	2007
Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 2006,Winter, Volume: 13, Issue:1 Topics: Aged; Akathisia, Drug-Induced; Anxiety; Female; Humans; Panic Disorder; Paroxetine; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome	2006
Antidepressant discontinuation: a review of the literature. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Newer antidepressants and the discontinuation syndrome. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7 Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7 Topics: Down-Regulation; Half-Life; Humans; Neurotransmitter Agents; Norepinephrine; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Syndrome	1997
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:7 Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1997
[Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case]. Praxis, 1998, Mar-04, Volume: 87, Issue:10 Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1998

Trials

20 trial(s) available for paroxetine and Substance Withdrawal Syndrome

Article	Year
Silexan does not cause withdrawal symptoms even when abruptly discontinued. International journal of psychiatry in clinical practice, 2017, Volume: 21, Issue:3 Topics: Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Humans; Lavandula; Oils, Volatile; Paroxetine; Plant Oils; Substance Withdrawal Syndrome	2017
Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Patient Satisfaction; Personality Inventory; Quality of Life; Substance Withdrawal Syndrome	2009
Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. International clinical psychopharmacology, 2002, Volume: 17, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Behavior; Substance Withdrawal Syndrome	2002
Onset of major depression during treatment for nicotine dependence. Addictive behaviors, 2003, Volume: 28, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder	2003
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:3 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Single-Blind Method; Substance Withdrawal Syndrome; Treatment Outcome	2003
Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study. Biological psychiatry, 2003, Sep-01, Volume: 54, Issue:5 Topics: Adult; Brain Mapping; Choline; Depressive Disorder, Major; Female; Fluoxetine; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Paroxetine; Phosphocreatine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome	2003
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study. International clinical psychopharmacology, 2004, Volume: 19, Issue:5 Topics: Acetamides; Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2004
Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine. Human psychopharmacology, 2004, Volume: 19, Issue:8 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Milnacipran; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome	2004
Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter. Journal of fluency disorders, 2005, Volume: 30, Issue:4 Topics: Adult; Anxiety; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Pimozide; Selective Serotonin Reuptake Inhibitors; Stuttering; Substance Withdrawal Syndrome; Treatment Outcome; Verbal Behavior	2005
Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS drugs, 2006, Volume: 20, Issue:8 Topics: Adult; Age Factors; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Depression; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Sex Factors; Substance Withdrawal Syndrome	2006
Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic. Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Benzodiazepines; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Internal Medicine; Male; Middle Aged; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome	2006
A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:4 Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Humans; Incidence; Male; Paroxetine; Placebos; Substance Withdrawal Syndrome; Time Factors	1995
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological psychiatry, 1998, Jul-15, Volume: 44, Issue:2 Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Health Status; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Surveys and Questionnaires	1998
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment. Psychoneuroendocrinology, 2000, Volume: 25, Issue:2 Topics: Adult; Biomarkers; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Hemodynamics; Hormones; Humans; Male; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Substance Withdrawal Syndrome	2000
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. The British journal of psychiatry : the journal of mental science, 2000, Volume: 176 Topics: Adult; Analysis of Variance; Double-Blind Method; Female; Fluoxetine; Humans; Male; Mental Disorders; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2000
Nicotine patch and paroxetine for smoking cessation. Journal of consulting and clinical psychology, 2000, Volume: 68, Issue:5 Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome	2000
Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: report on behalf of the Dutch Chronic Benzodiazepine Working Group. The British journal of psychiatry : the journal of mental science, 2001, Volume: 178 Topics: Adult; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Diazepam; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Sample Size; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2001
Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:8 Topics: Adult; Circadian Rhythm; Drug Administration Schedule; Equipment Design; Eyelids; Female; Fluvoxamine; Head; Humans; Longitudinal Studies; Male; Monitoring, Ambulatory; Monitoring, Physiologic; Movement; Paroxetine; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Stages; Sleep, REM; Substance Withdrawal Syndrome	2001
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2 Topics: Adolescent; Adult; Cytochrome P-450 CYP2D6 Inhibitors; Female; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	2002
Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS drugs, 2002, Volume: 16, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Dysthymic Disorder; Female; Fluoxetine; Humans; Interview, Psychological; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors	2002

Other Studies

67 other study(ies) available for paroxetine and Substance Withdrawal Syndrome

Article	Year
[Taperingstrips for paroxetine and venlafaxine]. Tijdschrift voor psychiatrie, 2013, Volume: 55, Issue:10 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Paroxetine; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2013
Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal. Neuroscience, 2014, Dec-05, Volume: 281 Topics: 5,7-Dihydroxytryptamine; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Disease Models, Animal; Hippocampus; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substance Withdrawal Syndrome	2014
Nocturnal enuresis after paroxetine abrupt discontinuation: a case report. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:5 Topics: Antidepressive Agents, Second-Generation; Female; Humans; Middle Aged; Nocturnal Enuresis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2008
Should paroxetine be used to treat depression during pregnancy? The American journal of psychiatry, 2008, Volume: 165, Issue:11 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Secondary Prevention; Substance Withdrawal Syndrome	2008
Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy. The journal of sexual medicine, 2009, Volume: 6, Issue:10 Topics: Bipolar Disorder; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Orgasm; Paroxetine; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Substance Withdrawal Syndrome; Time Factors	2009
Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cytochrome P-450 CYP2D6; Depressive Disorder; Drug Administration Schedule; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Risk Factors; Serotonin Plasma Membrane Transport Proteins; Substance Withdrawal Syndrome	2010
Dissecting dementia, depression, and drug effects in older adults. Journal of psychosocial nursing and mental health services, 2010, Volume: 48, Issue:1 Topics: Aged; Alzheimer Disease; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Nootropic Agents; Nursing Diagnosis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Substance Withdrawal Syndrome	2010
Hallucination induced by paroxetine discontinuation in patients with major depressive disorders. Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dizziness; Female; Hallucinations; Headache; Humans; Nausea; Paroxetine; Substance Withdrawal Syndrome	2011
Hippocampal agenesis in an individual who engaged in violent criminal behaviors after discontinuing carbamazepine and paroxetine treatment. Journal of forensic sciences, 2013, Volume: 58, Issue:1 Topics: Adolescent; Antidepressive Agents, Second-Generation; Antimanic Agents; Brain Mapping; Carbamazepine; Crime; Disruptive, Impulse Control, and Conduct Disorders; Forensic Psychiatry; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Medication Adherence; Paroxetine; Sexual Behavior; Substance Withdrawal Syndrome; Thalamus; Young Adult	2013
Selective serotonin reuptake inhibitor. Discontinuation syndrome. Journal of psychosocial nursing and mental health services, 2002, Volume: 40, Issue:12 Topics: Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Dizziness; Drug Administration Schedule; Humans; Male; Nurse Practitioners; Paroxetine; Patient Education as Topic; Psychiatric Nursing; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Refusal	2002
Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity. Neuropharmacology, 2003, Volume: 44, Issue:4 Topics: Animals; Brain; Corticosterone; Exploratory Behavior; Hydroxyindoleacetic Acid; Hypothermia; In Vitro Techniques; Male; Maze Learning; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Piperazines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Social Behavior; Substance Withdrawal Syndrome	2003
New dosage-reduction regime to avoid paroxetine discontinuation syndrome. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:2 Topics: Depressive Disorder; Dose-Response Relationship, Drug; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2003
Olanzapine and serotonin toxicity. Psychiatry and clinical neurosciences, 2003, Volume: 57, Issue:2 Topics: Antipsychotic Agents; Benzodiazepines; Citalopram; Drug Therapy, Combination; Humans; Olanzapine; Paroxetine; Pirenzepine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Substance Withdrawal Syndrome	2003
Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:4 Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Male; Paroxetine; Severity of Illness Index; Stroke; Substance Withdrawal Syndrome	2003
Paroxetine withdrawal syndrome. Prescrire international, 2003, Volume: 12, Issue:66 Topics: Humans; Paroxetine; Substance Withdrawal Syndrome	2003
Pharmaceutical companies under increased scrutiny. Behavioral healthcare tomorrow, 2003, Volume: 12, Issue:4 Topics: Consumer Advocacy; Drug Industry; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome; United States; United States Food and Drug Administration	2003
Delirium induced by abrupt discontinuation of paroxetine. The Journal of neuropsychiatry and clinical neurosciences, 2004,Winter, Volume: 16, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Delirium; Depressive Disorder, Major; Female; Humans; Paroxetine; Substance Withdrawal Syndrome	2004
Pruritus induced by interruption of paroxetine therapy. The British journal of dermatology, 2004, Volume: 150, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dermatologic Agents; Female; Humans; Middle Aged; Paroxetine; Pruritus; Substance Withdrawal Syndrome	2004
Re: Depression, stroke diagnosis, and SSRI discontinuation syndrome. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:5 Topics: Aged; Anxiety; Ataxia; Dementia, Multi-Infarct; Humans; Magnetic Resonance Imaging; Male; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2004
Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats. Psychopharmacology, 2005, Volume: 178, Issue:2-3 Topics: Affective Symptoms; Aminopyridines; Amphetamine; Animals; Brain; Drug Synergism; Hypothalamus, Posterior; Male; Motivation; Norepinephrine; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reward; Selective Serotonin Reuptake Inhibitors; Self Stimulation; Serotonin 5-HT1 Receptor Antagonists; Substance Withdrawal Syndrome	2005
[Methadone and sleep apnea syndrome]. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3 Topics: Adult; Brain; Clonidine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Hydroxyzine; Methadone; Methotrimeprazine; Opioid-Related Disorders; Paroxetine; Polysomnography; Sleep Apnea, Central; Sleep Stages; Substance Withdrawal Syndrome; Trimeprazine	2005
Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. European journal of clinical pharmacology, 2005, Volume: 61, Issue:4 Topics: Adult; Citalopram; Depression; Female; Fluoxetine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors	2005
Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2005, Volume: 27, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Counseling; Depression, Postpartum; Female; Humans; Mental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Psychotropic Drugs; Risk Factors; Substance Withdrawal Syndrome; Teratogens	2005
Antidepressant withdrawal symptoms-telephone calls to a national medication helpline. Journal of affective disorders, 2006, Volume: 95, Issue:1-3 Topics: Antidepressive Agents; Cyclohexanols; Hotlines; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Retrospective Studies; Substance Withdrawal Syndrome; Television; United Kingdom; Venlafaxine Hydrochloride	2006
Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic? Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Adjustment Disorders; Adolescent; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Buspirone; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Suicide, Attempted	2007
Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:5 Topics: Adult; Cyclohexanols; Female; Humans; Marijuana Smoking; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2008
Antidepressants in the postpartum period: additional considerations. The American journal of psychiatry, 2008, Volume: 165, Issue:2 Topics: Antidepressive Agents; Breast Feeding; Depression, Postpartum; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Psychotherapy; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Substance Withdrawal Syndrome	2008
Severe psychiatric symptoms associated with paroxetine withdrawal. Lancet (London, England), 1995, Jul-01, Volume: 346, Issue:8966 Topics: Adult; Behavior; Controlled Clinical Trials as Topic; Humans; Male; Mental Disorders; Middle Aged; Paroxetine; Stuttering; Substance Withdrawal Syndrome	1995
Physical symptoms associated with paroxetine withdrawal. The American journal of psychiatry, 1995, Volume: 152, Issue:8 Topics: Adult; Depressive Disorder; Dizziness; Ejaculation; Fatigue; Humans; Male; Middle Aged; Nausea; Paroxetine; Substance Withdrawal Syndrome; Tremor	1995
A possible paroxetine withdrawal syndrome. The American journal of psychiatry, 1995, Volume: 152, Issue:4 Topics: Adult; Akathisia, Drug-Induced; Female; Headache; Humans; Nausea; Paroxetine; Substance Withdrawal Syndrome; Syndrome; Vomiting	1995
Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors. The American journal of psychiatry, 1995, Volume: 152, Issue:5 Topics: 1-Naphthylamine; Adult; Anxiety Disorders; Electric Injuries; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Substance Withdrawal Syndrome	1995
Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning. European journal of pharmacology, 1995, Mar-06, Volume: 275, Issue:2 Topics: Analysis of Variance; Animals; Conditioning, Psychological; Disease Models, Animal; Drug Administration Schedule; Fluvoxamine; Injections, Subcutaneous; Male; Morphine; Naloxone; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders	1995
Paroxetine withdrawal syndrome. The American journal of psychiatry, 1995, Volume: 152, Issue:1 Topics: Adult; Anorexia; Anxiety Disorders; Depressive Disorder; Diarrhea; Dizziness; Female; Humans; Nausea; Paroxetine; Substance Withdrawal Syndrome	1995
Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:3 Topics: Adult; Dizziness; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Substance Withdrawal Syndrome	1994
Physical symptoms associated with paroxetine discontinuation. The American journal of psychiatry, 1994, Volume: 151, Issue:2 Topics: Adult; Depressive Disorder; Female; Humans; Influenza, Human; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Substance Withdrawal Syndrome	1994
SSRI withdrawal. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7 Topics: Humans; Muscarinic Agonists; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1996
Potential withdrawal syndrome associated with SSRI discontinuation. The Annals of pharmacotherapy, 1995, Volume: 29, Issue:12 Topics: 1-Naphthylamine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	1995
Withdrawal syndromes after paroxetine and sertraline discontinuation. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:5 Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	1995
More cases of paroxetine withdrawal syndrome. The British journal of psychiatry : the journal of mental science, 1996, Volume: 169, Issue:3 Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1996
Serotonin reuptake inhibitor withdrawal. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5 Topics: 1-Naphthylamine; Adolescent; Adult; Age Factors; Clomipramine; Dizziness; Female; Fluvoxamine; Humans; Male; Middle Aged; Paresthesia; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Substance Withdrawal Syndrome	1996
Lhermitte's sign in paroxetine withdrawal. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5 Topics: Adult; Central Nervous System Diseases; Depressive Disorder; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1996
Withdrawal after discontinuation of paroxetine. The Australian and New Zealand journal of psychiatry, 1996, Volume: 30, Issue:5 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Middle Aged; Neurologic Examination; Paroxetine; Substance Withdrawal Syndrome	1996
A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. British journal of clinical pharmacology, 1996, Volume: 42, Issue:6 Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	1996
Withdrawal hypomania associated with paroxetine. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Panic Disorder; Paroxetine; Substance Withdrawal Syndrome	1997
Antidepressant withdrawal syndrome. The British journal of psychiatry : the journal of mental science, 1997, Volume: 170 Topics: Antidepressive Agents, Second-Generation; Humans; Paroxetine; Substance Withdrawal Syndrome	1997
Paroxetine discontinuation syndrome in association with sertindole therapy. The British journal of psychiatry : the journal of mental science, 1997, Volume: 170 Topics: Adult; Antipsychotic Agents; Drug Interactions; Humans; Imidazoles; Indoles; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1997
Paroxetine withdrawal syndrome in a neonate. The British journal of psychiatry : the journal of mental science, 1997, Volume: 171 Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Infant, Newborn; Male; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Substance Withdrawal Syndrome	1997
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. European journal of clinical pharmacology, 1997, Volume: 53, Issue:3-4 Topics: 1-Naphthylamine; Adverse Drug Reaction Reporting Systems; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; World Health Organization	1997
Treatment of disequilibrium and nausea in the SRI discontinuation syndrome. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:8 Topics: Ataxia; Dizziness; Female; Humans; Nausea; Paroxetine; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Zingiberales	1998
Discontinuation symptoms and SSRIs. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10 Topics: Biological Availability; Depressive Disorder; Dizziness; Fluoxetine; Follow-Up Studies; Half-Life; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1998
Discontinuation of antidepressant therapy: emerging complications and their relevance. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10 Topics: Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; Syndrome; Terminology as Topic	1998
[Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)]. Ugeskrift for laeger, 1998, Dec-07, Volume: 160, Issue:50 Topics: Adult; Antidepressive Agents; Citalopram; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1998
[Severe withdrawal symptoms with fever during paroxetine tapering off]. Nederlands tijdschrift voor geneeskunde, 1999, Jul-03, Volume: 143, Issue:27 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Fever; Humans; Male; Paroxetine; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1999
[Severe withdrawal symptoms with fever upon stopping paroxetine]. Nederlands tijdschrift voor geneeskunde, 1999, Aug-28, Volume: 143, Issue:35 Topics: Drug Administration Schedule; Fever; Humans; Paroxetine; Pulse Therapy, Drug; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1999
[Severe withdrawal symptoms with fever upon stopping paroxetine]. Nederlands tijdschrift voor geneeskunde, 1999, Aug-28, Volume: 143, Issue:35 Topics: Citalopram; Drug Administration Schedule; Fever; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	1999
Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine? Journal of psychopharmacology (Oxford, England), 1999, Volume: 13, Issue:3 Topics: Analgesics, Opioid; Delirium; Female; Humans; Middle Aged; Morphine; Parathyroidectomy; Paroxetine; Postoperative Complications; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1999
Unilateral facial numbness and visual blurring associated with paroxetine discontinuation. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2 Topics: Antidepressive Agents, Second-Generation; Diagnosis, Differential; Facial Nerve Diseases; Humans; Hypesthesia; Male; Middle Aged; Paroxetine; Substance Withdrawal Syndrome; Vision Disorders	2000
[Withdrawal syndrome after the use of serotonin reuptake inhibitors]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2000, Mar-20, Volume: 120, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Depressive Disorder; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2000
[Paroxetine withdrawal syndrome]. Annales de medecine interne, 2000, Volume: 151 Suppl A Topics: Adult; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2000
Paroxetine and irritable bowel syndrome. The American journal of psychiatry, 2000, Volume: 157, Issue:9 Topics: Adult; Colonic Diseases, Functional; Comorbidity; Depressive Disorder; Drug Administration Schedule; Humans; Male; Paroxetine; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome	2000
Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:5 Topics: Antidepressive Agents, Second-Generation; Child; Depressive Disorder; Humans; Male; Paroxetine; Substance Withdrawal Syndrome	2000
Misdiagnosis of antidepressant discontinuation symptoms. Acta psychiatrica Scandinavica, 2000, Volume: 102, Issue:6 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Diagnosis, Differential; Dothiepin; Female; Humans; Middle Aged; Paroxetine; Substance Withdrawal Syndrome	2000
Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation. Canadian family physician Medecin de famille canadien, 2001, Volume: 47 Topics: Anti-Anxiety Agents; Antidepressive Agents; Evidence-Based Medicine; Female; Humans; Informed Consent; Lorazepam; Paroxetine; Patient Education as Topic; Preconception Care; Pregnancy; Risk Factors; Safety; Substance Withdrawal Syndrome	2001
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'. Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:2 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Diagnosis, Differential; Dysthymic Disorder; Female; Humans; Paroxetine; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2001
Withdrawal from paroxetine can be severe, warns FDA. BMJ (Clinical research ed.), 2002, Feb-02, Volume: 324, Issue:7332 Topics: Antidepressive Agents; Drug and Narcotic Control; Humans; Paroxetine; Substance Withdrawal Syndrome; United States	2002
Pathologic laughter associated with paroxetine treatment. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2 Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Laughter; Lithium Carbonate; Middle Aged; Paroxetine; Psychotic Disorders; Substance Withdrawal Syndrome	2002
Palinopsia and paroxetine withdrawal. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:4 Topics: Humans; Paroxetine; Perceptual Disorders; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Visual Perception	2002